These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3004720)

  • 1. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T; Sato H; Ogura H; Glaser R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The difference in tumorigenicity between Epstein-Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx.
    Takimoto T; Sato H; Ogura H; Tanaka S; Umeda R
    Laryngoscope; 1988 Dec; 98(12):1334-8. PubMed ID: 2849005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
    Takimoto T; Sato H; Ogura H; Ogura T; Ishikawa S; Iwawaki J
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(4):169-74. PubMed ID: 2819802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells.
    Takimoto T; Furukawa M; Hatano M; Umeda R
    Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
    Meerbach A; Friedrichs C; Thust R; Wutzler P
    Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
    Giunta S; Groppa G
    Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus.
    Roubal J; Roubalová K
    Acta Virol; 1985 Mar; 29(2):162-5. PubMed ID: 2860802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    Takimoto T; Ogura H; Sato H; Umeda R; Hatano M
    J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of Epstein-Barr virus (EBV)-related antigens and tumorigenicity in nude mice in a hybrid cell line derived from the fusion of an EBV-positive lymphoblastoid cell and an EBV-negative epithelial cell from the human nasopharynx].
    Ishiguro H
    Nihon Jibiinkoka Gakkai Kaiho; 1984 Jun; 87(6):693-707. PubMed ID: 6092593
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms of establishment and disruption of Epstein-Barr virus latency].
    Takada K
    Tanpakushitsu Kakusan Koso; 1989 Jun; 34(7):823-34. PubMed ID: 2552500
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
    Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
    Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
    Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
    Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
    Simonová I; Závadová H; Vonka V
    Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.